Major Pharmaceuticals drugs

45 results

  • Acyclovir (acyclovir)

    (Acyclovir)
    Major Pharmaceuticals
    Usage: Acyclovir tablets are indicated for the acute treatment of herpes zoster (shingles), management of initial and recurrent episodes of genital herpes, and treatment of chickenpox (varicella).

  • Allergy relief (diphenhydramine hcl)

    (Diphenhydramine HCl)
    Major Pharmaceuticals
    Usage: This drug temporarily relieves symptoms associated with hay fever or upper respiratory allergies, including runny nose, sneezing, itchy and watery eyes, and itching of the nose or throat.

  • Aminocaproic acid (aminocaproic acid)

    (Aminocaproic acid)
    Major Pharmaceuticals
    Usage: Aminocaproic acid tablets are indicated for enhancing hemostasis in cases of bleeding due to fibrinolysis, particularly following heart surgery, in hematological disorders, during acute abruptio placentae, hepatic cirrhosis, neoplastic diseases, and in excessive urinary tract bleeding from surgical or nonsurgical causes.

  • Budesonide (budesonide)

    (budesonide)
    Major Pharmaceuticals
    Usage: Budesonide delayed-release capsules are indicated for treating mild to moderate active Crohn's disease in patients aged 8 and older and for maintaining clinical remission of the disease in adults for up to 3 months, specifically targeting the ileum and/or ascending colon.

  • Bumetanide (bumetanide)

    (Bumetanide)
    Major Pharmaceuticals
    Usage: Bumetanide tablets are used to treat edema related to congestive heart failure, hepatic and renal diseases, including nephrotic syndrome. They can be administered orally or via intramuscular/intravenous routes if gastrointestinal absorption is impaired. There is no cross-sensitivity with furosemide in allergic reactions.

  • Bupropion hydrochloride (bupropion hydrochloride)

    (Bupropion Hydrochloride)
    Major Pharmaceuticals
    Usage: Bupropion hydrochloride tablets are indicated for the treatment of major depressive disorder (MDD) in adults, as established in controlled clinical trials.

  • Bupropion hydrochloride (bupropion hydrochloride)

    (bupropion hydrochloride)
    Major Pharmaceuticals
    Usage: Bupropion hydrochloride extended-release tablets (XL) are indicated for treating major depressive disorder (MDD) and for preventing seasonal major depressive episodes in patients with seasonal affective disorder (SAD), based on established efficacy from controlled clinical trials.

  • Buspirone hydrochloride (buspirone hydrochloride)

    (Buspirone Hydrochloride)
    Major Pharmaceuticals
    Usage: Buspirone hydrochloride tablets are indicated for managing anxiety disorders, particularly Generalized Anxiety Disorder (GAD), and providing short-term relief from anxiety symptoms. While effective in patients with coexisting depressive symptoms, its long-term efficacy beyond 3-4 weeks has not been confirmed. Regular reassessment of treatment necessity is advised.

  • Carbamazepine (carbamazepine)

    (Carbamazepine)
    Major Pharmaceuticals
    Usage: Carbamazepine is indicated as an anticonvulsant for treating partial seizures with complex symptomatology, generalized tonic-clonic seizures, and mixed seizure patterns. It is also used to treat pain from trigeminal neuralgia and has shown benefits for glossopharyngeal neuralgia, but is not for minor pain relief.

  • Cephalexin (cephalexin)

    (Cephalexin)
    Major Pharmaceuticals
    Usage: Cephalexin is indicated for treating respiratory tract infections, otitis media, skin infections, bone infections, and genitourinary tract infections caused by specific susceptible bacteria. It should be used judiciously to minimize drug resistance, considering culture data and local susceptibility patterns when available.